Wert202020212022202320242025TTMMittelzufluss aus Investitionstätigkeit-47.36 M87 K66.19 M-44.45 M59.97 M-9.62 M—Zahlungsströme aus der Finanzierungstätigkeit69.63 M6.88 M51.78 M134.19 M54.78 M263.31 M224.57 MFreier Cashflow-33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-137.51 M-150.95 M
Verastem, Inc. - Common Stock
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.